Citadel Advisors’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-163,892
| Closed | -$5.27M | – | 14796 |
|
|
2022
Q1 | $5.27M | Buy |
163,892
+143,101
| +688% | +$3.87M | ﹤0.01% | 4071 |
|
|
2021
Q4 | $550K | Buy |
+20,791
| New | +$529K | ﹤0.01% | 9463 |
|
|
2021
Q3 | – | Sell |
-30,642
| Closed | -$727K | – | 15140 |
|
|
2021
Q2 | $806K | Sell |
30,642
-40,432
| -57% | -$1.02M | ﹤0.01% | 8924 |
|
|
2021
Q1 | $1.59M | Sell |
71,074
-79,693
| -53% | -$1.83M | ﹤0.01% | 6969 |
|
|
2020
Q4 | $2.95M | Buy |
150,767
+60,410
| +67% | +$1M | ﹤0.01% | 4609 |
|
|
2020
Q3 | $1.27M | Buy |
90,357
+29,737
| +49% | +$429K | ﹤0.01% | 5598 |
|
|
2020
Q2 | $686K | Buy |
60,620
+41,746
| +221% | +$381K | ﹤0.01% | 6514 |
|
|
2020
Q1 | $119K | Sell |
18,874
-320,289
| -94% | -$5.17M | ﹤0.01% | 8509 |
|
|
2019
Q4 | $6.9M | Buy |
339,163
+74,350
| +28% | +$1.39M | ﹤0.01% | 2657 |
|
|
2019
Q3 | $4.4M | Sell |
264,813
-50,805
| -16% | -$879K | ﹤0.01% | 3285 |
|
|
2019
Q2 | $5.19M | Sell |
315,618
-446,926
| -59% | -$8.62M | ﹤0.01% | 3024 |
|
|
2019
Q1 | $13.4M | Buy |
762,544
+173,450
| +29% | +$3.69M | 0.01% | 1727 |
|
|
2018
Q4 | $14.6M | Buy |
589,094
+541,112
| +1,128% | +$18M | 0.01% | 1495 |
|
|
2018
Q3 | $1.54M | Sell |
47,982
-15,752
| -25% | -$537K | ﹤0.01% | 4835 |
|
|
2018
Q2 | $2.24M | Sell |
63,734
-44,609
| -41% | -$1.65M | ﹤0.01% | 3931 |
|
|
2018
Q1 | $4.3M | Buy |
108,343
+30,143
| +39% | +$1.17M | ﹤0.01% | 2633 |
|
|
2017
Q4 | $2.86M | Buy |
78,200
+45,639
| +140% | +$1.73M | ﹤0.01% | 3159 |
|
|
2017
Q3 | $1.33M | Sell |
32,561
-43,497
| -57% | -$1.69M | ﹤0.01% | 3926 |
|
|
2017
Q2 | $3.03M | Sell |
76,058
-38,704
| -34% | -$1.29M | ﹤0.01% | 2646 |
|
|
2017
Q1 | $3.34M | Buy |
114,762
+27,054
| +31% | +$714K | ﹤0.01% | 2468 |
|
|
2016
Q4 | $2M | Sell |
87,708
-62,884
| -42% | -$1.48M | ﹤0.01% | 2953 |
|
|
2016
Q3 | $3.98M | Buy |
+150,592
| New | +$3.04M | ﹤0.01% | 2212 |
|
|
2016
Q1 | – | Sell |
-6,371
| Closed | -$82K | – | 8365 |
|
|
2015
Q4 | $82K | Sell |
6,371
-58,435
| -90% | -$711K | ﹤0.01% | 6887 |
|
|
2015
Q3 | $721K | Sell |
64,806
-169,683
| -72% | -$2.07M | ﹤0.01% | 4264 |
|
|
2015
Q2 | $2.81M | Buy |
234,489
+132,938
| +131% | +$2.21M | ﹤0.01% | 2663 |
|
|
2015
Q1 | $2M | Buy |
101,551
+1,524
| +2% | +$31.9K | ﹤0.01% | 3065 |
|
|
2014
Q4 | $1.99M | Buy |
100,027
+14,874
| +17% | +$243K | ﹤0.01% | 2920 |
|
|
2014
Q3 | $1.36M | Buy |
+85,153
| New | +$1.44M | ﹤0.01% | 3314 |
|
|
2014
Q1 | – | Sell |
-12,768
| Closed | -$197K | – | 8085 |
|
|
2013
Q4 | $196K | Buy |
12,768
+11,793
| +1,210% | +$167K | ﹤0.01% | 5048 |
|
|
2013
Q3 | $18K | Buy |
+975
| New | +$17.6K | ﹤0.01% | 6276 |
|
Other funds holding TVTY
BCMLT
PP
IA
Citadel Advisors's TVTY Position: Q2 2022 in Review
Citadel Advisors sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 163,892 shares — an estimated $5.27M sold.
Citadel Advisors first reported a position in TVTY in Q3 2013 and held it in 30 quarters. The position peaked at $14.6M in Q4 2018. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Citadel Advisors reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Citadel Advisors sold 163,892 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $5.27M.
- Citadel Advisors first reported a position in Tivity Health, Inc. Common Stock in Q3 2013 and held it in 30 quarters.
- Citadel Advisors's Tivity Health, Inc. Common Stock position peaked at $14.6M in Q4 2018.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.